Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAOMI: Neoadjuvant Letrozole for ER+ Breast Cancer
NCT04568616Phase 2Active, not recruiting
- Sponsor
- Dartmouth Health
- Start
- Aug 2021
- Primary completion
- Apr 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in breast cancer, sponsored by Dartmouth Health. Started Aug 2021; status: active, not recruiting.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04568616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04568616.